Department of Chemistry, University of Massachusetts-Amherst, Amherst, Massachusetts, United States.
Anal Chem. 2013 Feb 5;85(3):1591-6. doi: 10.1021/ac302829k. Epub 2013 Jan 8.
Arylsulfatase A is an endogenous enzyme that is responsible for the catabolism and control of sulfatides in humans. Its deficiency results in the accumulation of sulfatides in the cells of the central and peripheral nervous system leading to the destruction of the myelin sheath and resulting in metachromatic leukodystrophy (MLD), a neurodegenerative lysosomal storage disease. A recombinant human form of this glycoprotein (rhASA) is currently under development as an enzyme replacement therapy. At neutral and alkaline pH, this protein exists as a homodimer but converts to an octameric state in the mildly acidic environment of the lysosome, and a failure to form an octamer results in suboptimal catalytic activity (most likely due to a diminished protection from lysosomal proteases). Despite the obvious importance of the rhASA oligomerization process, its mechanistic details remain poorly understood. In this work, we use size exclusion chromatography (SEC) and electrospray ionization mass spectrometry (ESI MS) to monitor the dimer-to-octamer transition as a function of both solution pH and protein concentration. While SEC clearly shows different profiles (i.e., retention time differences) for rhASA when the chromatography is performed at neutral and lysosomal pH, consistent with changing oligomerization states, no resolved peaks could be observed for either octamer or dimer when analyzed at intermediate pH (5.5-6.5). This could be interpreted either as the result of a rapid dimer-to-octamer interconversion on the chromatographic time scale or as a consequence of the presence of previously unidentified intermediate species (e.g., tetramer and/or hexamer). In contrast, ESI MS provides strong evidence of the dimer-to-octamer transition state that occurs when the analysis is performed within a narrow pH range (6.0-7.0). Octamer assembly was shown to be a highly cooperative process with no intermediate states that are populated to detectable levels. A tetrameric state of rhASA exists at equilibrium with a dimer at neutral pH but does not appear to be involved in the octamer assembly process.
芳基硫酸酯酶 A 是一种内源性酶,负责人类中硫酸酯的分解代谢和控制。其缺乏导致硫酸酯在中枢和周围神经系统细胞中的积累,导致髓鞘的破坏,并导致异染性脑白质营养不良(MLD),一种神经退行性溶酶体贮积病。这种糖蛋白的重组人形式(rhASA)目前正在作为酶替代疗法进行开发。在中性和碱性 pH 值下,该蛋白以同源二聚体形式存在,但在溶酶体的微酸性环境中转化为八聚体状态,如果不能形成八聚体,则催化活性不理想(最有可能是由于对溶酶体蛋白酶的保护减弱)。尽管 rhASA 寡聚化过程非常重要,但对其机制细节仍知之甚少。在这项工作中,我们使用尺寸排阻色谱(SEC)和电喷雾电离质谱(ESI-MS)来监测二聚体到八聚体的转变作为溶液 pH 值和蛋白质浓度的函数。虽然 SEC 清楚地显示了 rhASA 在中性和溶酶体 pH 下进行色谱分离时的不同图谱(即保留时间差异),这与不断变化的寡聚化状态一致,但在中间 pH 值(5.5-6.5)下分析时,无法观察到八聚体或二聚体的任何分辨峰。这可能解释为在色谱时间尺度上快速的二聚体到八聚体的相互转化的结果,或者是由于存在以前未识别的中间物质(例如四聚体和/或六聚体)的结果。相比之下,ESI-MS 提供了在狭窄 pH 范围内进行分析时发生二聚体到八聚体转变状态的有力证据。八聚体组装是一个高度协作的过程,没有中间状态可以达到可检测的水平。rhASA 的四聚体状态在中性 pH 值下与二聚体处于平衡状态,但似乎不参与八聚体组装过程。